Catalent drops $350M to expand Indiana site that includes Moderna-dedicated line
Bloomington, IN, is the home of Indiana Hoosiers basketball – and the center of Catalent’s biologics drug substance manufacturing operations. And while the university’s forward …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.